Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Amur, AIQ, Baron,

Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Amur, AIQ, Baron,
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health, is pleased to announce that the project subject to the Evaluation
Bens Creek Group (BEN), the owner of a metallurgical coal mine in North America, said that it was notified on 4 July 2022 by John Story that, following a sale
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Bens, Cornish, DeepVerge,
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health, is today providing an update on its proposed sub-license agreement with
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is Bidstack, Baron Oil, Best, DeepMatter, GST,
Zak Mir takes a charting look at some of the most followed small caps on the London market. Today’s selection includes Arrow Exploration, Aura, Bidstack, Cyan, Diurnal, Eco, Galantas, Goldstone,
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health today provides an update on progress towards the completion of the
Hydrogen Utopia International (HUI), a company pioneering non-recyclable waste plastics to hydrogen technology, updated as to the implications of the current invasion of Ukraine by Russia.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection includes Abingdon, Avacta, Cloudbreak, Gfinity, Greenroc, Genedrive, Ncondezi, Tlou,
London, UK – ValiRx Plc (AIM: VAL), a life science company focusing on early-stage cancer therapeutics and women’s health, today provides an update on operational activities and strategy.